000 | 01985 a2200613 4500 | ||
---|---|---|---|
005 | 20250518100020.0 | ||
264 | 0 | _c20200804 | |
008 | 202008s 0 0 eng d | ||
022 | _a2041-1723 | ||
024 | 7 |
_a10.1038/s41467-020-15726-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLee, Jenny H | |
245 | 0 | 0 |
_aTranscriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition. _h[electronic resource] |
260 |
_bNature communications _c04 2020 |
||
300 |
_a1897 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanoma _xgenetics |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xdrug effects |
650 | 0 | 4 | _aTranscriptome |
650 | 0 | 4 |
_aTumor Microenvironment _xdrug effects |
700 | 1 | _aShklovskaya, Elena | |
700 | 1 | _aLim, Su Yin | |
700 | 1 | _aCarlino, Matteo S | |
700 | 1 | _aMenzies, Alexander M | |
700 | 1 | _aStewart, Ashleigh | |
700 | 1 | _aPedersen, Bernadette | |
700 | 1 | _aIrvine, Malama | |
700 | 1 | _aAlavi, Sara | |
700 | 1 | _aYang, Jean Y H | |
700 | 1 | _aStrbenac, Dario | |
700 | 1 | _aSaw, Robyn P M | |
700 | 1 | _aThompson, John F | |
700 | 1 | _aWilmott, James S | |
700 | 1 | _aScolyer, Richard A | |
700 | 1 | _aLong, Georgina V | |
700 | 1 | _aKefford, Richard F | |
700 | 1 | _aRizos, Helen | |
773 | 0 |
_tNature communications _gvol. 11 _gno. 1 _gp. 1897 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41467-020-15726-7 _zAvailable from publisher's website |
999 |
_c30879446 _d30879446 |